Lipidic last breath of life in patients with alcoholic liver disease

Prostaglandins and Other Lipid Mediators

Volumn 99, Issue 1-2, 2012, Pages 51-56

  Raszeja Wyszomirska, Joanna ^a   Safranow, Krzysztof ^a   Milkiewicz, Małgorzata ^a   Milkiewicz, Piotr ^a   Szynkowska, Agnieszka ^a   Stachowska, Ewa ^a  

^a POMERANIAN MEDICAL UNIVERSITY   (Poland)

Author keywords

Alcoholic liver disease; HETE; HODE; Linoleic and arachidonic acid derivatives; Lipoxygenases (LOXs)

Indexed keywords

12 HYDROXYICOSATETRAENOIC ACID; 13 HYDROXYOCTADECADIENOIC ACID; 15 HYDROXYICOSATETRAENOIC ACID; 15 LIPOXYGENASE 1; 15 LIPOXYGENASE 2; 5 HYDROXYICOSATETRAENOIC ACID; 8 EPI PROSTAGLANDIN F2 ALPHA III; 9 HYDROXYOCTADECADIENOIC ACID; ARACHIDONATE 15 LIPOXYGENASE; ARACHIDONATE 5 LIPOXYGENASE; ARACHIDONIC ACID; LINOLEIC ACID; MESSENGER RNA; PROSTAGLANDIN F2 ALPHA; UNCLASSIFIED DRUG;

ADULT; ALCOHOL LIVER DISEASE; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENDER; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LIPID BLOOD LEVEL; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; PROTEIN EXPRESSION;

ADULT; AGED; FATTY ACIDS, UNSATURATED; FATTY LIVER; FEMALE; HUMANS; HYDROXYEICOSATETRAENOIC ACIDS; LIPID PEROXIDATION; LIPOXYGENASES; LIVER; LIVER CIRRHOSIS, ALCOHOLIC; LIVER DISEASES, ALCOHOLIC; MALE; MIDDLE AGED;

EID: 84865518380     PISSN: 10988823     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.prostaglandins.2012.06.001     Document Type: Article

References (27)

1. M.S. Sozio, S. Liangpunsakul, and D. Crabb The role of lipid metabolism in the pathogenesis of alcoholic and nonalcoholic hepatic steatosis Semin Liver Dis 30 2010 378 390
2. A.D. Dobrian, D.C. Lieb, B.K. Cole, D.A. Taylor-Fishwick, S.K. Chakrabarti, and J.L. Nadler Functional and pathological roles of the 12- and 15-lipoxygenases Prog Lipid Res 50 2011 115 131
3. Y. Yoshida, and E. Niki Bio-markers of lipid peroxidation in vivo: hydroxyoctadecadienoic acid and hydroxycholesterol Biofactors 27 2006 195 202
4. A.M. Patwardhan, A.N. Akopian, N.B. Ruparel, A. Diogenes, S.T. Weintraub, and C. Uhlson Heat generates oxidized linoleic acid metabolites that activate TRPV1 and produce pain in rodents J Clin Invest 120 2010 1617 1626
5. P. Puri, M.M. Wiest, and O. Cheung The plasma lipidomic signature of nonalcoholic steatohepatitis Hepatology 50 6 2009 1827 1838
6. I. Shureiqi, D. Chen, and R.S. Day Profiling lipoxygenase metabolism in specific steps of colorectal tumorigenesis Cancer Prev Res (Phila) 3 2010 829 838
7. H. Yuan, M.Y. Li, and L.T. Ma 15-Lipoxygenases and its metabolites 15(S)-HETE and 13(S)-HODE in the development of non-small cell lung cancer Thorax 65 2010 321 326
8. R. Colas, V. Pruneta-Deloche, and M. Guichardant Increased lipid peroxidation in LDL from type-2 diabetic patients Lipids 45 2010 723 731
9. N. Shibata, S. Toi, and T. Shibata Immunohistochemical detection of 13(R)-hydroxyoctadecadienoic acid in atherosclerotic plaques of human carotid arteries using a novel specific antibody Acta Histochem Cytochem 42 2009 197 203
10. A.E. Feldstein, R. Lopez, and T.A. Tamimi Mass spectrometric profiling of oxidized lipid products in human nonalcoholic fatty liver disease and nonalcoholic steatohepatitis J Lipid Res 51 2010 3046 3054
11. J. Raszeja-Wyszomirska, G. Kurzawski, I. Zawada, J. Suchy, J. Lubinski, and P. Milkiewicz HFE gene mutations in patients with alcoholic liver disease Pol Arch Med Wewn 120 2010 127 130
12. M. Hamaguchi, T. Kojima, Y. Itoh, Y. Harano, K. Fujii, and T. Nakajima The severity of ultrasonographic findings in nonalcoholic fatty liver disease reflects the metabolic syndrome and visceral fat accumulation Am J Gastroenterol 102 2007 2708 2715
13. D.E. Kleiner, E.M. Brunt, M. Van Natta, C. Behling, M.J. Contos, and O.W. Cummings Nonalcoholic steatohepatitis clinical research network design and validation of a histological scoring system for nonalcoholic fatty liver disease Hepatology 41 2005 1313 1321
14. E. Stachowska, V. Dziedziejko, and K. Safranow Effect of conjugated linoleic acids on the activity and mRNA expression of 5- and 15-lipoxygenases in human macrophages J Agric Food Chem 55 2007 5335 5342
15. R.L. Smathers, J.J. Galligan, and B.J. Stewart Overview of lipid peroxidation products and hepatic protein modification in alcoholic liver disease Chem Biol Interact 192 2011 107 112
16. P.W. Pemberton, A. Smith, and T.W. Warnes Non-invasive monitoring of oxidant stress in alcoholic liver disease Scand J Gastroenterol 40 2005 1102 1108
17. K. Asayama, T. Nakane, N. Uchida, H. Hayashibe, K. Dobashi, and S. Nakazawa Serum antioxidant status in streptozotocin-induced diabetic rats Horm Metab Res 26 1994 313 315
18. G. Chinetti, J.C. Fruchart, and B. Staels Peroxisome proliferator- activated receptors (PPARs): nuclear receptors with functions in the vascular wall Z Kardiol 90 2001 125 132
19. T. Mello, S. Polvani, and A. Galli Peroxisome proliferator-activated receptor and retinoic x receptor in alcoholic liver disease PPAR Res 2009 2009 748174
20. M. Martínez-Clemente, N. Ferré, and A. González- Périz 5-Lipoxygenase deficiency reduces hepatic inflammation and tumor necrosis factor alpha-induced hepatocyte damage in hyperlipidemia-prone ApoE-null mice Hepatology 51 2010 817 827
21. K. Lötzer, C.D. Funk, and A.J. Habenicht The 5-lipoxygenase pathway in arterial wall biology and atherosclerosis Biochim Biophys Acta 1736 1 2005 30 37
22. R. Horrillo, A. González-Périz, and M. Martínez- Clemente 5-Lipoxygenase activating protein signals adipose tissue inflammation and lipid dysfunction in experimental obesity J Immunol 184 2010 3978 3987
23. E. Titos, J. Clria, and A. Planagum Inhibition of 5-lipoxygenase- activating protein abrogates experimental liver injury: role of Kupffer cells J Leukoc Biol 78 2005 871 878
24. J. Wittwer, and M. Hersberger The two faces of the 15-lipoxygenase in atherosclerosis Prostaglandins Leukot Essent Fatty Acids 77 2007 67 77
25. S.K. Chakrabarti, B.K. Cole, and Y. Wen 12/15-Lipoxygenase products induce inflammation and impair insulin signaling in 3T3-L1 adipocytes Obesity (Silver Spring) 17 2009 1657 1663
26. S.K. Chakrabarti, Y. Wen, and A.D. Dobrian Evidence for activation of inflammatory lipoxygenase pathways in visceral adipose tissue of obese Zucker rats Am J Physiol Endocrinol Metab 300 2011 E175 E177
27. K. Ma, C.S. Nunemaker, and R. Wu 12-Lipoxygenase products reduce insulin secretion and {beta}-cell viability in human islets J Clin Endocrinol Metab 95 2010 887 893